High Court's Sorrell Ruling Yet To Transform Drug Marketing

High Court's Sorrell Ruling Yet To Transform Drug Marketing

The U.S. Supreme Court's 2011 ruling in Sorrell v. IMS Health set the stage for looser limits on off-label promotion by drugmakers, but experts say the upshot for Big Pharma has been hard to gauge, as the U.S. Food and Drug Administration continues ...read more

  • Tags: